We are IntechOpen, the world's leading publisher of Open Access books Built by scientists, for scientists

6,500+ Open access books available

175,000+

190M+

Downloads

International authors and editors

156 Countries delivered to Our authors are among the

Top 1% most cited scientists

12.2%

Contributors from top 500 universities

Selection of our books indexed in the Book Citation Index in Web of Science™ Core Collection (BKCI)

### Interested in publishing with us? Contact book.department@intechopen.com

Numbers displayed above are based on latest data collected. For more information visit www.intechopen.com

## Meet the editors

Qiang Yan, MD, FACS, is the vice president of Huzhou Central Hospital and academic leader of the Department of General Surgery and the Department of Hepatopancreatic and Biliary Surgery, Huzhou Central Hospital, Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, China. He is a fellow of the Chinese College of Surgeons and a core member of the Committee of Biliary Surgeons, Committee of Minimal

and Non-invasive Surgeons, the Chinese Medical Doctor Association (CMDA), and many other academic associations. He is also an editorial board member of the *Chinese Journal of General Surgery, Liver Cancer, and the Chinese Journal of Clinicians.* He is enrolled in the Zhejiang Province New Century 151 Excellent Talents Program. He has finished advanced studies for hepatobiliary pancreatic surgery at Medical Center, Stanford University and Affiliated Hospital, Regensburg University. He got the certificate of Surgical Leadership Program of Harvard Medical School in September 2019. He has more than thirty publications to his credit.

Dr. Zhiping Pan is a medical doctor in the Division of Hepatopancreatic and Biliary (HPB) Surgery, Department of General Surgery, Zhejiang University Huzhou Hospital, China. He is a core member of the hepatobiliary and pancreatic surgery team led by Dr. Qiang Yan. He focuses on the accurate diagnosis and minimally invasive surgical treatment of hepatobiliary and pancreatic diseases.

### Contents


**Section 5** Bile Duct Injury **83**

### **Chapter 6 85**

Iatrogenic Biliary Injury Surgical Management *by Alex Zendel and Yaniv Fenig*

Preface

Biliary system diseases are a common pathology in medical practice. The biliary tree is characterized by bile duct branches at multiple levels, with innumerable variations present in each branch, giving rise to an increasing geometric progression of biliary anatomy types. Therefore, as an organ, the biliary tract has a certain complexity in the occurrence and development of its disease. The management of biliary tract disease

This book discusses the natural history, clinical presentation, diagnosis, and medical and surgical management strategies of the varying pathologies that make up biliary diseases such as common bile duct stones (CBDS), choledochal cyst (CC), gallbladder cancer (GBCa), and bile duct injury (BDI). CBDS is a chronic recurrent hepatobiliary disorder that can trigger serious complications, including obstructive jaundice, acute suppurative cholangitis, and acute pancreatitis. Early diagnosis and prompt treatment are the most important factors in managing CBDS. CC, also known as congenital bile duct dilatation, presents with extrahepatic bile duct dilatation. In patients with jaundice, abdominal pain, and a palpable abdominal mass, physicians must have a high clinical suspicion of CC. The biggest challenge in the surgical management is how to ensure the long-term patency of the postoperative biliary system and prevent subsequent strictures, stones and carcinogenesis. GBCa is the most common cancer of the biliary system and has a very poor prognosis when diagnosed at a late stage. Cancer may also present with mild, vague symptoms such as loss of appetite, chronic abdominal discomfort, weight loss, pruritus, scleral icterus, and jaundice. The diagnosis of GBCa is based on a combination of multiple dimensions including history, physical examination, imaging, or biopsy. The treatment of GBCa remains difficult at present. There are few cases amenable to surgical resection, and it again has a low response rate to most adjuvant therapies. BDI is a very feared complication after gallbladder surgery. It occurs because the biliary tract and its blood supply cannot be avoided during dissection. Its most common symptoms are persistent abdominal pain, bloating, nausea and/or vomiting, fever, and jaundice. While its different injury

remains a challenging and emerging area of investigation.

types and degrees determine different surgical repair modalities.

diseases.

This book is designed to help clinicians better understand and treat biliary system

**Qiang Yan and Zhiping Pan** Department of General Surgery, Huzhou Central Hospital,

Hu Zhou, China

## Preface

Biliary system diseases are a common pathology in medical practice. The biliary tree is characterized by bile duct branches at multiple levels, with innumerable variations present in each branch, giving rise to an increasing geometric progression of biliary anatomy types. Therefore, as an organ, the biliary tract has a certain complexity in the occurrence and development of its disease. The management of biliary tract disease remains a challenging and emerging area of investigation.

This book discusses the natural history, clinical presentation, diagnosis, and medical and surgical management strategies of the varying pathologies that make up biliary diseases such as common bile duct stones (CBDS), choledochal cyst (CC), gallbladder cancer (GBCa), and bile duct injury (BDI). CBDS is a chronic recurrent hepatobiliary disorder that can trigger serious complications, including obstructive jaundice, acute suppurative cholangitis, and acute pancreatitis. Early diagnosis and prompt treatment are the most important factors in managing CBDS. CC, also known as congenital bile duct dilatation, presents with extrahepatic bile duct dilatation. In patients with jaundice, abdominal pain, and a palpable abdominal mass, physicians must have a high clinical suspicion of CC. The biggest challenge in the surgical management is how to ensure the long-term patency of the postoperative biliary system and prevent subsequent strictures, stones and carcinogenesis. GBCa is the most common cancer of the biliary system and has a very poor prognosis when diagnosed at a late stage. Cancer may also present with mild, vague symptoms such as loss of appetite, chronic abdominal discomfort, weight loss, pruritus, scleral icterus, and jaundice. The diagnosis of GBCa is based on a combination of multiple dimensions including history, physical examination, imaging, or biopsy. The treatment of GBCa remains difficult at present. There are few cases amenable to surgical resection, and it again has a low response rate to most adjuvant therapies. BDI is a very feared complication after gallbladder surgery. It occurs because the biliary tract and its blood supply cannot be avoided during dissection. Its most common symptoms are persistent abdominal pain, bloating, nausea and/or vomiting, fever, and jaundice. While its different injury types and degrees determine different surgical repair modalities.

This book is designed to help clinicians better understand and treat biliary system diseases.

> **Qiang Yan and Zhiping Pan** Department of General Surgery, Huzhou Central Hospital, Hu Zhou, China

**1**

Section 1

Introduction

Section 1 Introduction

### **Chapter 1**

## Introductory Chapter: Biliary Tract – Review and Recent Progress

*Qiang Yan and Zhiping Pan*

### **1. Introduction**

### **1.1 Biliary diseases**

Biliary diseases are common digestive system disorders in clinical practice worldwide. Diseases in this segment of the biliary tract are diverse and can manifest with mild clinical signs or can be life-threatening. These diseases exert their effects on our normal lives and have an impact on our physical well-being. It is important to correctly recognize the features of these disorders and, with the right management options in hand. It presents a challenge for every clinician. This book discusses the work-up, diagnosis, and management of the varying pathologies that make up biliary disease including common bile duct stones (CBDS), choledochal cyst (CC), gallbladder cancer (GBCa), and bile duct injury (BDI). Therefore, it can provide clinicians with a platform to learn about these disorders in order to better serve patients.

### **2. Chronic recurrent hepatobiliary disease**

CBDS is a chronic recurrent hepatobiliary disease whose pathological bases are impaired cholesterol, bilirubin, and bile acid metabolism. The incidence of cholelithiasis is 5% to 15%, in the incidence of CBDS is about 5–30% [1]. This is also associated with serious complications, including obstructive jaundice, acute suppurative cholangitis, and acute pancreatitis. Early diagnosis and prompt treatment are the most important for managing CBDS [2]. Endoscopic ultrasonography (EUS) and magnetic resonance cholangiopancreatography (MRCP) have high sensitivity, specificity, and accuracy for the diagnosis of CBDS. At present, it is recommended that patients with CBDS be treated with minimally invasive surgery promptly after diagnosis to reduce iatrogenic trauma or complications caused by surgery based on expelling the stones. The endoscopic retrograde cholangiopancreatography (ERCP) and laparoscopic transcystic common bile duct exploration (LTCBDE) approaches have become two different minimally invasive treatments for choledocholithiasis [3]. Their advantages of good curative effect, small trauma, quick recovery, and fewer complications have been recognized by the majority of medical workers.

### **3. Congenital biliary dilation**

CC, also known as congenital biliary dilation, presents as the dilation of extrahepatic bile ducts. It has a worldwide incidence of about 1:100,000 to 1:150,000 but the incidence can be as high as 1 in 1000 in Asians [4]. Todani classification focuses on the location and morphology of the lesions and classifies intrahepatic and extrahepatic dilated bile ducts into five types, which are currently the most widely used. CC is a rare anomaly that is sometimes considered a precancerous lesion, which often poses a diagnostic dilemma. The typical presentation of this condition is nonspecific. The medical team must have a high level of clinical suspicion for choledochal cysts when investigating patients with jaundice, abdominal pain, and palpable abdominal masses. Because of these symptoms and the ambiguity of the physical findings, appropriate imaging studies are essential for their diagnosis [5]. The three major principles of surgical management of CC are total cyst resection, resolution of stenosis, and biliopancreatic diversion. The bilio jejunal Roux-en-Y anastomosis is currently the standard surgical procedure for biliary reconstruction. The biggest challenge in the surgical management of biliary cysts is how to ensure long-term postoperative biliary system patency and prevent subsequent strictures, stones, and carcinogenesis. This requires the physician to build systematic thinking preoperatively about the complex conditions and anatomic features that bile duct cysts may combine to properly and meticulously address key intraoperative details.

### **4. GBCa**

GBCa is the most common cancer of the biliary tract system and is ranked as the top six in general gastrointestinal tract neoplasms worldwide [6]. Due to the aggressive behavior and limited treatment options available for GBCa, the prognosis is very poor at late diagnosis. Early detection at a curable stage remains challenging because patients rarely manifest symptoms; indeed, most GBCs are discovered incidentally following cholecystectomy for symptomatic gallbladder stones. Cancer can also present with subtle, vague symptoms such as loss of appetite, chronic abdominal discomfort, weight loss, pruritus, scleral icterus, and jaundice. The diagnosis of GBCa is based on a combination of history, physical examination, laboratory tests, radiological imaging (ultrasound, CT, MRI, and/or PET), and biopsy. Long-standing chronic inflammation is an important driver of GBC, regardless of the lithiasic or non-lithiasic origin. Advances in omics technologies have led to a greater understanding of GBC pathogenesis, revealing mechanisms associated with inflammation-driven tumorigenesis and progression. Surgical resection is the only curative treatment for GBC, but cases suitable for resection are rare and response rates to most adjuvant therapies are very low. Several unmet clinical needs require to be addressed to improve GBC management, including the discovery and validation of reliable biomarkers for screening, treatment selection, and prognosis [7].

### **5. BDI**

BDI is still a much-feared complication following gallbladder surgery. It occurs because of the inability to avoid the biliary tract and its blood supply during dissection. Several factors are associated with an increased risk of BDI associated with cholecystectomy. These include the inability to clearly identify the cystic duct prior

### *Introductory Chapter: Biliary Tract – Review and Recent Progress DOI: http://dx.doi.org/10.5772/intechopen.111488*

to clipping or dividing, surgery for acute cholecystitis, the presence of choledocholithiasis, anatomic variations in the anatomy of the biliary tree, and emergency surgery [8]. The most common complaints of BDI patients are persistent abdominal pain, abdominal distension, nausea and/or vomiting, fever, and jaundice [9]. The clinical manifestations of BDI are related to the type of injury. The two most common clinical conditions are biliary leakage and biliary obstruction. Strasberg classification of BDI is fairly comprehensive for defining the type and extent of injury and guiding surgical repair. The effective surgical management of low-grade Strasberg types A-D injuries can include biliary drainage, primary repair of the bile duct, or duct-to-duct biliary reconstruction. High-grade Strasberg type E injuries should be always repaired with Roux-en-Y hepatojejunostomy [10].

This book covers the above four common diseases of the biliary tract. A focused and concise introduction to the basic concepts, clinical manifestations, diagnosis, and therapeutic measures of each disease is given. It is hoped that this book will help physicians at large to reinforce their personal experience and standardize the behavior of clinical diagnosis and treatment of biliary-related diseases, becoming a powerful helper for front-line clinical workers.

### **Author details**

Qiang Yan1,2,3,4,5,6\* and Zhiping Pan1,2,3,4,5,6

1 Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, Zhejiang, China

2 Department of General Surgery, Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, Zhejiang, China

3 Department of General Surgery, Affiliated Huzhou Central Hospital, Huzhou University School of Medicine, Huzhou, Zhejiang, China

4 Department of General Surgery, Zhejiang Chinese Medical University, The Fifth School of Clinical Medicine, Huzhou, Zhejiang, China

5 Huzhou Key Laboratory of Intelligent and Digital Precision Surgery, Huzhou, Zhejiang, China

6 Department of General Surgery, Huzhou Central Hospital, Huzhou Key Laboratory of Intelligent and Digital Precision Surgery, Huzhou, Zhejiang, China

\*Address all correspondence to: yanqiangdoc@hotmail.com

© 2023 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

### **References**

[1] Deng F, Zhou M, Liu PP, et al. Causes associated with recurrent choledocholithiasis following therapeutic endoscopic retrograde cholangiopancreatography: A large sample sized retrospective study. World Journal of Clinical Cases. 2019;**7**(9):1028-1037

[2] Wu Y, Xu CJ, Xu SF. Advances in risk factors for recurrence of common bile duct stones. International Journal of Medical Sciences. 2021;**18**(4):1067-1074

[3] Zhang R, Liu J, Li H, Zeng Q, Wu S, Tian H. Evaluation of therapeutic efficacy, safety and economy of ERCP and LTCBDE in the treatment of common bile duct stones. Frontiers in Physiology. 2022;**13**:949452

[4] Ye Y, Lui VCH, Tam PKH. Pathogenesis of choledochal cyst: Insights from genomics and transcriptomics. Genes (Basel). 2022;**13**(6):1030

[5] Hoilat GJ, John S. Choledochal Cyst. Treasure Island (FL): StatPearls Publishing; 2022

[6] Song X, Hu Y, Li Y, et al. Overview of current targeted therapy in gallbladder cancer. Signal Transduction and Targeted Therapy. 2020;**5**(1):230

[7] Roa JC, García P, Kapoor VK, et al. Gallbladder cancer. Natural Review in Diseases Primers. 2022;**8**(1):69. DOI: 10.1038/s41572-022-00398-y

[8] Ahmad DS, Faulx A. Management of postcholecystectomy biliary complications: A narrative review. The American Journal of Gastroenterology. 2020;**115**(8):1191-1198

[9] Mercado MA, Domínguez I. Classification and management of bile duct injuries. World Journal of Gastrointestinal Surgery. 2011;**3**(4):43-48

[10] de Angelis N, Catena F, Memeo R, et al. 2020 WSES guidelines for the detection and management of bile duct injury during cholecystectomy. World Journal of Emergency Surgery. 2021;**16**(1):30

Section 2

## Common Bile Duct Stones

### **Chapter 2** Bile Duct Stones

*Diego Rossi Kleinübing, Lailson Alves Rodrigues and Sarah Luiz Brum*

### **Abstract**

Common bile duct stones (CBDS) incidence is about 10–15%. Clinical signs and symptoms are nonspecific but when associated with biochemical tests and abdominal ultrasound, patients can be categorized into low, intermediate, and high risk of choledocholithiasis. These clinical, biochemical, and radiological predictors will direct the diagnostic approach through cholangio magnetic resonance, endoscopic ultrasound, laparoscopic ultrasound, or intraoperative cholangiography. Treatment options must consider technological availability, technical skills, stone size, and bile duct diameter. In general, it involves endoscopic retrograde cholangiopancreatography or surgery for CBDS clearance. For difficult stones, endoscopic sphincterotomy followed by large balloon dilation, mechanical lithotripsy, cholangioscopy-guided lithotripsy, and extracorporeal shock wave lithotripsy are described, mainly as a bridge procedure.

**Keywords:** gallbladder stones, choledocholithiasis, bile duct stones predictors, bile duct stone diagnosis, bile duct stones treatment

### **1. Introduction**

Gallbladder stone disease has an overall prevalence of approximately 15%. Choledocholithiasis is present in about 10–20% of patients with symptomatic cholelithiasis [1–5]. Secondary choledocholithiasis remains the leading cause of common bile duct stones (CBDS), originating from migration of gallbladder stones into hepatocholedochal duct, while primary choledocholithiasis is a rare cause, mainly affecting the eastern population [4, 6].

The pathophysiology of secondary CBDS is the same as for gallbladder stones. Most gallstones are composed of cholesterol, due to the supersaturation of the bile, leading microcrystals formation. These cholesterol crystals, incorporated into vesicular mucin and associated with bile stasis, form gallstones. While 80–90% are cholesterol gallstones, primary choledocholitiasis is related to brown stones, whose formation occurs directly in the common bile duct (CBD), resulting from mechanical obstruction of bile flow, leading to stasis with subsequent bacterial colonization. However, sometimes there is no obstructive factor, such as bile duct stricture or papillary stenosis. Therefore, dilated CBD, especially after cholecystectomy, is an important factor for primary CBDS [7–9].

Due to the multifactorial etiology of gallbladder stones, CBDS predominates in female gender aged over 55 years, with dietary, genetic, and hormonal associated

factors, as metabolic syndrome, obesity, rapid weight loss, family history, pregnancy, multiparity, and oral contraceptives [4, 7, 8].

Symptomatology is quite varied, ranging from completely asymptomatic patients to classic clinical manifestations of biliary lithiasis, such as epigastric or right upper abdominal pain, nausea and vomiting, to obstructive symptoms as fluctuant jaundice, choluria, and acholia. Eventually, patients may present with other complications of choledocholithiasis, for example, acute pancreatitis or cholangitis [6, 10].

Recurrent primary choledocholithiasis is a chronic pathology conceptually characterized by recurrence of common bile duct stones after, at least, 6 months of cholecystectomy. Some risk factors are bile duct greater than 13–15 mm in diameter and with angle smaller than 145°, presence of periampullary diverticulum, biliary stricture or papilla stenosis, and identification of two or more stones in bile duct [3, 11–13].

There are specific predictors of choledocholithiasis, which include clinical findings (obstructive jaundice, acute pancreatitis, or cholangitis), abnormal hepatogram, and presence of a choledochal stone or bile duct dilatation >8 mm [3, 4]. Based on this, patients are stratified in low, intermediate, or high risk of choledocholithiasis which will guide all diagnostic effort and, therefore, treatment approach [1, 2, 6, 14].

### **2. Diagnosis**

Clinical manifestations of choledocholithiasis are nonspecific such as epigastric or upper abdominal pain, nausea, vomiting, and fluctuating jaundice. History of acute pancreatitis, cholangitis, and jaundice are suggestive of choledocholithiasis, since nearly 50% of acute biliary pancreatitis and most cholangitis are caused by stones in the common bile duct (CBD) [6, 15].

Screening for choledocholithiasis includes clinical, biochemical (gamma-glutamyl transpeptidase (GGT), alkaline phosphatase (AF), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and bilirubin) and ultrasound showing CBD greater than 6 mm. These predictors, when normal, have high power to rule out the presence of choledocholithiasis, considering their negative predictive value is greater than 97% [5].

The initial evaluation with predictive factors allows us to stratify patients into high, intermediate, and low probability of choledocholithiasis. These factors are clinical evidence of acute cholangitis, bilirubin greater than 1.7 mg/dL, visualization of common bile duct stone, and dilated CBD on abdominal ultrasound. When two of these factors are present, the probability of choledocholithiasis is high, whereas with normal common bile duct diameter without cholangitis, the probability is low. Patients between these two spectra are stratified as having intermediate probability for diagnosis [3].

Based on the initial screening assessment, when the suspicion of choledocholithiasis is low, laparoscopic cholecystectomy (LC) is recommended. If it is intermediate, the options are endoscopic ultrasound (EUS), magnetic resonance cholangiopancreatography, or even computed tomography (CT scan) in the preoperative period, according to local availability. During intraoperative suspect, laparoscopic ultrasound (LUS) or intraoperative cholangiography (IOC) is indicated [3, 11].

### **2.1 Abdominal ultrasound**

Ultrasound consists of an inexpensive, noninvasive, and widely available method; however, it is operator-dependent with limitations in obese patients in the investigation of choledocholithiasis. The most important contribution is to demonstrate

**Figure 1.** *Ultrasound showing common bile duct dilated (2.28×4.19 cm) with a 2.2 cm stone.*

dilation of the CBD above 6 mm at the time of initial screening, although its normality does not exclude the diagnosis [3, 6, 11, 16]. The sensitivity is 73% and specificity is 91% [11]. As we can see in **Figure 1,** the common bile duct is located over the portal vein and the common bile duct stone typically produces posterior acoustic shadow.

### **2.2 Magnetic resonance cholangiopancreatography**

It is recommended in cases of intermediate suspicion of choledocholithiasis, that is, patients with altered biochemical tests, aged >55 years and dilatation of the common bile duct on ultrasound [4], consisting of a noninvasive option, with sensitivity >90% and specificity close to 100%. This accuracy is reduced for stones smaller than 3 mm. It is normally required for the diagnosis of choledocholithiasis before endoscopic intervention or surgical exploration [2].

It suggests choledocholithiasis on T2 when evidence of fluid (bile) as a bright, high-intensity signal on images. Solid material may be suggested by the filling failure—hypointense and well delimited—within the common bile duct, as we see in **Figure 2** [6].

It is contraindicated in patients with claustrophobia, obesity, cardiac pacemakers, or metal clips [3, 4].

### **2.3 Endoscopic and laparoscopic ultrasound**

Endoscopic ultrasound (EUS) is a diagnostic method based on the introduction of an endoscope with an ultrasound transducer into the duodenal bulb, with specificity about 90% and sensitivity of 97% for CBD stones detection [4]. It is indicated mainly for patients who cannot perform magnetic resonance cholangiopancreatography (MRCP), that is, those who have intracranial metallic clips, pacemakers, mechanical heart valves, claustrophobia, and morbid obesity. Its main disadvantage is related to invasiveness, need for anesthetic sedation, and reduced availability. In addition, EUS

**Figure 2.** *MRCP showing common bile duct dilated (1.3 cm in diameter) with 0.6 cm stone at distal portion (circle).*

is operator-dependent, which also makes it more expensive. Patients with gastric bypass present an important limitation of this method [4, 11].

Laparoscopic ultrasound consists in a specific laparoscopic probe used directly over the common bile duct and is indicated for patients with intermediate risk during intraoperative period which has not been detected by initial investigation by MRCP or EUS [3, 6]. With sensibility estimated in 95% and specificity near 100% [17], its main limitation is proximal biliary tree stone evaluation [18].

The stones are suggested by hyperechoic foci with posterior acoustic shadowing [6].

### **2.4 Endoscopic retrograde cholangiopancreatography (ERCP)**

Method performed by combining upper digestive endoscopy and fluoroscopy presents sensitivity around 82% and specificity near 90% for the CBDS diagnosis. Main disadvantages of this method are invasiveness and risk of pancreatitis in 5–10% of patients. Currently, endoscopic retrograde cholangiopancreatography (ERCP) has been reserved for therapeutic purposes for patients diagnosed with choledocholithiasis by MRCP, endoscopic ultrasound, or even computed tomography [3, 6].

### **2.5 Computed tomography (CT scan)**

Although not routinely used, this method is indicated when the hypotheses of common bile duct stones and a tendency to malignancy coexist or in absence of ERCP or MRCP. Its sensitivity is 78% and specificity is 96%, with reduced accuracy if CBDS <5 mm or bile-like density [6, 11].

There is an option for diagnosing choledocholithiasis with contrast-enhanced CT cholangiography, but contrast is poorly available [6].

As a disadvantage, contrast injection and exposure to ionizing radiation are described [6]. In **Figure 3,** we can see the stone in a patient with right upper abdominal pain and fluctuant jaundice.

**Figure 3.** *CT scan showing distal bile duct stone (white circle).*

### **2.6 Intraoperative cholangiography (IOC)**

It consists in a useful method to delineate the anatomy of the biliary tree and to demonstrate the presence of intraoperative common bile duct stones. It exhibits sensitivity of 75–99% and specificity around 90–100% for the diagnosis of choledocholithiasis, especially when correlated with clinical, biochemical, and ultrasound findings [2, 5].

IOC can be selectively indicated in patients at high risk of choledocholithiasis undergoing cholecystectomy (history of jaundice, cholangitis or pancreatitis, abnormal biochemical tests, and a CBD > 8 mm in the US) or routinely in all consecutive patients candidates to cholecystectomy, irrespective the risk of CBDS. However, the selective or routine indication remains controversial in the literature. Currently, as we can see in **Figure 4**, IOC is still considered the gold standard for intraoperative biliary anatomy evaluation [4, 5, 19].

### **3. Treatment**

The management of choledocholithiasis is based on bile duct clearance and cholecystectomy, as most ductal stones migrate from gallbladder. Therefore, all patients with common bile duct stones, symptomatic or not, should be managed with gallbladder removal to treat the cause and to avoid recurrence of this chronic hepatobiliary pathology [1, 3, 6].

The approach of the CBDS depends on local technological resources availability, technical skills, moment of diagnosis, stone size, and common bile duct diameter [2, 3].

The treatment of choledocholithiasis involves, in general aspects, ERCP or surgical exploration of the common bile duct, laparoscopic, or open [1, 6]. Therefore, in

**Figure 4.** *Intraoperative cholangiography showing intra and extrahepatic bile duct dilation.*

non-cholecystectomy patients with choledocholithiasis, CBDS smaller than 1 cm and bile duct with diameter until 1.5 cm, preoperative ERCP followed by laparoscopic cholecystectomy is preferred. In case of unavailable ERCP, the option is to proceed with intraoperative cholangiography, bile duct exploration, and cholecystectomy in a unique procedure, laparoscopic, or open approach. When diagnosis is confirmed intraoperatively by cholangiography or LUS, it is possible to proceed with intraoperative ERCP or surgical exploration in the same surgical act, depending on the surgeon's experience, biliary anatomy, and available resources. Another possibility is to proceed with postoperative ERCP [3]. Finally, in cholecystectomy patients, postoperative ERCP is the gold standard therapy [1, 3, 6]. We emphasize that stone size greater than 1.5 cm and CBD diameter greater than 1.5 cm, if considered isolated or together, are predictors of higher rates of success by surgical exploration than ERCP.

There are no differences in the success rates of gallstone removal regarding pre-, intra-, or postoperative ERCP, which is estimated around 80–90%. However, intraoperative ERCP has lower complication rates and faster hospital discharge. Ideally, as it is performed in a unique time, intraoperative approach is quite advantageous, but the dynamics, resources, and necessary structure are major disadvantages of this strategy [1]. Despite the high success rates in clearance of choledocholithiasis, ERCP presents risks and complications, especially post-ERCP pancreatitis, followed by infection, bleeding, and perforation of the bile ducts. Although there is no definitive consensus, there is a general preference for preoperative ERCP, due to the assurance that there is no more distal obstruction, reducing the need for another intervention [2]. Besides, an interval of up to 2 weeks after ERCP is recommended to proceed with LC [1, 11].

In stones larger than 1.5 cm, endoscopic sphincterotomy followed by large balloon dilation (12–20 mm), mechanical lithotripsy, cholangioscopy-guided lithotripsy, and extracorporeal shock wave lithotripsy are described, mainly as a bridge procedure to definitive ERCP or surgical approach. However, it must be emphasized that this size of stone is normally followed by bile duct dilation, which needs necessarily be considered when one chooses the treatment options [1, 4, 6, 11].

Therefore, stones larger than 1.5 cm, multiple bile duct stones (>15), tortuous biliary anatomy, and a CBD diameter > 2 cm present difficulty of endoscopic and laparoscopic removal, being predictors of open procedure, which will probably evolve

### *Bile Duct Stones DOI: http://dx.doi.org/10.5772/intechopen.106634*

associated biliodigestive derivation, preferably choledochojejunostomy Roux-en-Y derivation, to avoid biliary stasis and consequently recurrent choledocholithiasis. Choledochojejunostomy is preferred over choledochoduodenostomy due to lower rates of stone recurrence and complications such as sump syndrome **Figure 5** [1–4, 6, 11, 20–24].

The main complications of surgical treatment are biliary leak at choledochotomy suture or at bile duct-enteric anastomosis, biloma, common bile duct stenosis which may cause also recurrent choledocholithiasis, pancreatic or bile duct injury due to instrumentation, and recurrent ascendent cholangitis mainly with choledochoduodenostomy technique [21, 23–25].

Bile leaks are prevented following general principles of anastomosis as tensionfree and well-perfused anastomotic stumps, biliary, and enteric. It is also the crucial anatomical knowledge of common bile duct axial vascularization when performing choledochotomy, which must be longitudinal to avoid vascular section, for bile duct exploration and stones removal. Additionally, one must be certified of the absence of distal bile duct obstruction before proceeding with choledochotomy suture. The occurrence of biliary leak, despite all these precautions, has benign behavior and closes spontaneously in most cases when drain-oriented placed intraoperatively or after biloma percutaneous drainage [26, 27].

### **Figure 5.**

*Diagnosis approach of common bile duct stones flowchart. US: ultrasound, CBD: common bile duct, LFT: liver function tests, EUS: endoscopic ultrasound, MRCP: magnetic resonance cholangiopancreatography, CT Scan: computed tomography, IOC: intraoperative cholangiography, ERCP: endoscopic retrograde cholangiopancreatography.*

Biliary strictures are preferably managed through ERCP or transhepatic dilation, depending on the height of bile duct stricture and the magnitude of stenosis. Surgical management with redo anastomosis, a difficult procedure considering previous manipulation, is reserved when endoscopic or percutaneous approach fails [26–29].

The preference for hepatic or choledochojejunostomy is recommended to avoid recurrent ascendent cholangitis also known as sump syndrome [24, 27].

New perspectives, mainly minimally invasive, for bile duct stones treatment include cholangioscopy-guided lithotripsy, extracorporeal shock wave lithotripsy, and laser lithotripsy under direct visualization through ureteroscopes or choledochoscopes employment [30]. SpyGlass™ system is a new device for high-resolution cholangioscopy which may be combined with electrohydraulic lithotripsy during ERCP or with laser lithotripsy, specially applied for difficult bile duct stones [31].

Although not yet widely available and clearly established by the guidelines, all these techniques could be used as adjunct to ERCP or laparoscopic bile duct exploration in order to improve one-step resolution rates in case of simultaneous gallbladder

### **Figure 6.**

*Management of common bile duct stones flowchart. ERCP: endoscopic retrograde cholangiopancreatography, LC: laparoscopic cholecystectomy, IOC: intraoperative cholangiography, LUS: laparoscopic ultrasound, EHL: cholangioscopy-guided electrohydraulic lithotripsy, LL: laser lithotripsy.*

### *Bile Duct Stones DOI: http://dx.doi.org/10.5772/intechopen.106634*

stones or common bile duct clearance if residual choledocholithiasis, according to technical skills development [3, 4, 11, 30, 31].

The summary of management is summarized in **Figure 6**.

### **4. Conclusions**

Bile duct stones is relatively prevalent condition. In patients with gallbladder, the diagnostic effort must include both silent and suspected stone based on clinical, biochemical, and radiological predictors of choledocholithiasis, in the cholecystectomy preoperative period. Once stratified as intermediate or high risk, the investigation will proceed according to local resources availability, preferably with MRCP and ERCP, respectively. The treatment will depend on several factors to be considered, such as the moment of diagnosis, stone size and number, bile duct diameter, ERCP availability, and technical skills. Considering all these factors, the surgeon must propose the best available approach to your patient.

### **Acknowledgements**

We wish to express our gratitude to Santa Casa de Caridade de Uruguaiana, Brazil, where our medical care develops.

We would like to thank Universidade Federal do Pampa, Uruguaiana, Brazil, where our research, teaching, and learning activities develop.

### **Conflict of interest**

The authors declare no conflict of interest.

### **Abbreviations**


*Biliary Tract – Review and Recent Progress*

### **Author details**

Diego Rossi Kleinübing1,2\*, Lailson Alves Rodrigues1 and Sarah Luiz Brum1

1 Federal University of Pampa, Uruguaiana, Brazil

2 Hepatobiliary Surgery, HSCU, Uruguaiana, Brazil

\*Address all correspondence to: diegokleinubing@unipampa.edu.br

© 2023 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

### **References**

[1] Tazuma S, Unno M, Igarashi Y, Inui K, Uchiyama K, Kai M, et al. Evidencebased clinical practice guidelines for cholelithiasis 2016. Journal of Gastroenterology. 2017;**52**(3):276-300

[2] Dasari BVM, Tan CJ, Gurusamy KS, Martin DJ, Kirk G, McKie L, et al. Surgical versus endoscopic treatment of bile duct stones. Cochrane Database of Systematic Reviews. 2013;(12) Art. No.: CD003327. DOI: 10.1002/14651858.CD003327.pub4

[3] Narula VK, Fung EC, Overby DW, Richardson W, Stefanidis D. Clinical spotlight review for the management of choledocholithiasis. Surgical Endoscopy. 2020;**34**(4):1482-1491

[4] Buxbaum J, Fehmi S, Sultan S, Fishman D, Qumseya B, Cortessis V, et al. ASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasis. Gastrointestinal Endoscopy. 2019;**89**:1075-1105

[5] Kleinubing DR, Riera R, Matos D, Linhares MM. Selective versus routine intraoperative cholangiography for cholecystectomy. Cochrane Database of Systematic Reviews. 2018, 2022;(2) Art. No.: CD012971. DOI: 10.1002/14651858. CD012971. Accessed 15 June

[6] Williams E, Beckingham I, El Sayed G, Gurusamy K, Sturgess R, Webster G, et al. Updated guideline on the management of common bile duct stones (CBDS). Gut. 2017;**66**(5):765-782

[7] Attasaranya S, Fogel E, Lehman G. Choledocholithiasis, ascending cholangitis, and gallstone pancreatitis. Medical Clinics of North America. 2008;**92**:925-960

[8] Wilkins T, Agabin E, Varghese J, Talukder A. Gallbladder dysfunction: Cholecystitis, choledocholithiasis,

cholangitis, and biliary dyskinesia. Primary Care Clinics in Office Practice. Dec 2017;**44**(4):575-597. DOI: 10.1016/j. pop.2017.07.002. Epub 2017 Oct 5. PMID: 29132521

[9] Saharia P, Zuidema G, Cameron J. Primary common duct stones. Presented at the Annual Meeting of the Southern Surgical Association. 1976. pp. 5-8

[10] Chae MK, Lee SH, Joo KR. Assessment of the possible risk factors for primary common bile duct stone recurrence after cholecystectomy. Surgical Endoscopy. 2020;**35**(12):6497-6504

[11] Manes G, Paspatis G, Aabakken L, Anderloni A, Arvanitakis M, Ah-Soune P, et al. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2019;**51**(05):472-491

[12] van Dijk AH, de Reuver PR, BesselinkMG, van Laarhoven KJ, Harrison EM, Wigmore SJ, et al. Assessment of available evidence in the management of gallbladder and bile duct stones: A systematic review of international guidelines. HPB. 2017;**19**(4):297-309

[13] Yoo ES, Yoo BM, Kim JH, Hwang JC, Yang MJ, Lee KM, et al. Evaluation of risk factors for recurrent primary common bile duct stone in patients with cholecystectomy. Scandinavian Journal of Gastroenterology. 2018;**53**(4):466-470

[14] Wu Y, Xu CJ, Xu SF. Advances in risk factors for recurrence of common bile duct stones. International Journal of Medical Sciences. 2021;**18**(4):1067-1074

[15] Sperna Weiland CJ, Busch CB, Bhalla A, Bruno MJ, Fockens P, et al. Performance of diagnostic tools for acute cholangitis in patients with suspected biliary obstruction. Journal of Hepato-Biliary-Pancreatic Sciences. 2022;**29**(4):479-486

[16] Horrow MM. Ultrasound of the extrahepatic bile duct: Issues of size. Ultrasound Quarterly. 2010;**26**(2):67-74

[17] Donoghue S, Jones RM, Bush A, Srinivas G, Bowling K, Andrews S. Cost effectiveness of intraoperative laparoscopic ultrasound for suspected choledocholithiasis; outcomes from a specialist benign upper gastrointestinal unit. The Annals of The Royal College of Surgeons of England. 2020;**102**(8):598-600

[18] Atstupens K, Mukans M, Plaudis H, Pupelis G. The Role of laparoscopic ultrasonography in the evaluation of suspected choledocholithiasis. A singlecenter experience. Medicina (Kaunas). 2020;**56**(5):246

[19] de Araujo TB, Jotz GP, Zaki CH, Mantelli RA, Fernandes VF, Pretto GG, et al. Intraoperative cholangiography with filling defects: comparative complication analysis of postoperative transcystic duct (TCD) catheter maintenance. Surgical Endoscopy. 2021;**35**(12):6438-6448

[20] Râmboiu S, Ghita F, Raluca-Elena N, Gororgescu I. The role of biliodigestive derivations in the tratment of choledocholithiasis. Current Health Sciences Journal. 2011;**37**(4):181-184

[21] Shojaiefard A, Esmaeilzadeh M, Ghafouri A, Mehrabi A. Various techniques for the surgical treatment of common bile duct stones: A meta review. Gastroenterology Research Practice. 2009:1-12. DOI: 10.1155/2009/840208. Epub 2009 Aug 6. PMID: 19672460; PMCID: PMC2722154

[22] Park CY, Choi SH, Kwon CI, Cho JH, Jang SI, Lee TH, et al. What is the better surgical treatment option for recurrent common bile duct stones? Annals of Surgical Treatment and Research. 2020;**99**(6):329-336

[23] Abraham H, Thomas S, Srivastava A. Sump syndrome: A rare long-term complication of choledochoduodenostomy. Case Reports in Gastroenterology. 2017;**11**(2):428-433

[24] Cho CS, D'Angelica MI. Bile duct exploration and biliary-enteric anastomosis. In: Jarnagin WR, editor. Blumgart's Surgery of the Liver, Biliary Tract, and Pancreas. Vol. 5th. Philadelphia: Elsevier Saunders; 2012

[25] Moore MD, McIntyre CA, Eachempati S. Management of complications from biliary surgery. In: Moore L, Todd S, editors. Common Problems in Acute Care Surgery. Springer Cham; 7 Dec 2016. DOI: 10.1007/978- 3-319-42792-8. eBook ISBN 978-3-319-42792-8

[26] Anderson CD, Scoggins CR, Chari RS. Reoperative Hepatobiliary Surgery. In: Callery MP, editor. Handbook of Reoperative General Surgery. Malden: Blackwell Publishing Inc.; 2006. pp. 1-16

[27] Kim JY, Kim KW, Ahn C, Hwang S, Lee Y, Shin YM, et al. Spectrum of biliary and nonbiliary complications after laparoscopic cholecystectomy: Radiologic findings. American Journal of Roentgenology. 2008;**191**:783-789

[28] Bismuth H, Majno PE. Biliary strictures: Classification based on the principles of surgical treatment. World Journal of Surgery. 2001;**25**:1241-1244

[29] Strasberg SM, Hawkins W. Reconstruction of the bile duct: *Bile Duct Stones DOI: http://dx.doi.org/10.5772/intechopen.106634*

Anatomic principles and surgical techniques. In: Fisher JE, Bland KI, editors. Mastery of Surgery. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. pp. 1128-1144

[30] Bosley ME, Zamora IJ, Neff LP. Choledocholithiasis—A new clinical pathway. Translational Gastroenterology and Hepatology. 2021;**6**:35

[31] Liu YJWQ. Efficacy and safety of SpyGlass system combined with electrohydraulic lithotripsy during endoscopic retrograde cholangiopancreatography in treatment of difficult common bile duct stones. Journal of Clinical Hepatology. 2021;**37**(7):1644-1647
